EX-99.2 3 g94865exv99w2.htm EX-99.2 FINANCIAL TABLES EX-99.2 FINANCIAL TABLES
 

Exhibit 99.2

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

                 
    Three Months Ended  
    March 31,  
    2005     2004  
Revenue
  $ 303,934     $ 271,214  
Costs and expenses:
               
Cost of operations
    172,163       162,642  
Development and engineering
    14,640       11,096  
Sales, marketing, general and administrative
    82,137       76,994  
Depreciation and amortization
    16,504       12,585  
Legal expense
    4,160       2,037  
Loss on investments
    3,832       84  
Interest income
    4,321       5,483  
Interest expense
    4,781       4,748  
Other income, net
          121  
 
           
Income before income tax provision
    10,038       6,632  
Income tax provision
    189       931  
 
           
Net income
  $ 9,849     $ 5,701  
 
           
Net income per common share:
               
Basic
  $ 0.03     $ 0.02  
 
           
Diluted
  $ 0.03     $ 0.02  
 
           
Weighted-average shares outstanding used in computing net income per common share:
               
Basic
    325,334       311,011  
 
           
Diluted
    335,689       327,402  
 
           

 


 

WebMD CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

                 
    Three Months Ended  
    March 31,  
    2005     2004  
Revenues
               
WebMD Business Services
  $ 185,733     $ 163,779  
WebMD Practice Services
    73,018       71,006  
WebMD Health
    33,575       26,309  
Porex
    19,856       18,421  
Inter-segment eliminations
    (8,248 )     (8,301 )
 
           
 
  $ 303,934     $ 271,214  
 
           
Income before taxes, non-cash and other items
               
WebMD Business Services
  $ 38,253     $ 29,850  
WebMD Practice Services
    4,397       1,351  
WebMD Health
    4,851       4,542  
Porex
    5,397       5,042  
Corporate
    (13,626 )     (13,305 )
Interest income
    4,321       5,483  
Interest expense
    (4,781 )     (4,748 )
 
           
 
    38,812       28,215  
Basic income per common share before taxes, non-cash and other items (a)
  $ 0.12     $ 0.09  
 
           
Diluted income per common share before taxes, non-cash and other items (a)
  $ 0.12     $ 0.09  
 
           
 
Taxes, non-cash and other items (b)
               
Depreciation and amortization
    (16,504 )     (12,585 )
Amortization of prepaid content and services (included in cost of operations)
          (255 )
Amortization of prepaid content and services (included in sales, marketing, general and administrative)
    (2,627 )     (5,038 )
Non-cash stock compensation (included in sales, marketing, general and administrative)
    (1,651 )     (1,705 )
Legal expense
    (4,160 )     (2,037 )
Loss on investments
    (3,832 )     (84 )
Income tax provision
    (189 )     (931 )
Other income, net
          121  
 
           
Net income
  $ 9,849     $ 5,701  
 
           
Net income per common share:
               
Basic
  $ 0.03     $ 0.02  
 
           
Diluted
  $ 0.03     $ 0.02  
 
           
Weighted-average shares outstanding used in computing net income per common share:
               
Basic
    325,334       311,011  
 
           
Diluted
    335,689       327,402  
 
           


(a)   Basic and diluted income per common share before taxes, non-cash and other items are based on the weighted-average shares outstanding used in computing basic and diluted income per common share.
 
(b)   Reconciliation of income before taxes, non-cash and other items to net income.

 


 

WebMD CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)

                 
    March 31,     December 31,  
    2005     2004  
Assets
               
Cash and cash equivalents
  $ 42,754     $ 46,019  
Short-term investments
    130,690       61,675  
Accounts receivable, net
    231,450       214,437  
Inventory
    13,844       13,978  
Prepaid expenses and other current assets
    38,421       40,613  
 
           
Total current assets
    457,159       376,722  
 
Marketable debt securities
    396,220       511,864  
Marketable equity securities
    3,331       4,017  
Property and equipment, net
    93,778       89,677  
Goodwill
    1,030,948       1,010,564  
Intangible assets, net
    263,074       260,509  
Other assets
    45,815       48,871  
 
           
 
  $ 2,290,325     $ 2,302,224  
 
           
Liabilities and Stockholders’ Equity
               
Accounts payable
  $ 8,423     $ 17,366  
Accrued expenses
    161,588       201,528  
Deferred revenue
    122,866       109,533  
 
           
Total current liabilities
    292,877       328,427  
 
Convertible subordinated notes
    649,999       649,999  
Other long-term liabilities
    1,236       1,283  
 
Convertible redeemable exchangeable preferred stock
    98,357       98,299  
 
Stockholders’ equity
    1,247,856       1,224,216  
 
           
 
  $ 2,290,325     $ 2,302,224  
 
           

 


 

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

                 
    Three Months Ended  
    March 31,  
    2005     2004  
Cash flows from operating activities:
               
Net income
  $ 9,849     $ 5,701  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    16,504       12,585  
Amortization of debt issuance costs
    726       746  
Non-cash content and distribution services
    2,627       5,293  
Non-cash stock-based compensation
    1,651       1,705  
Bad debt expense
    2,283       1,472  
Loss on investments
    3,832       84  
Gain on sale of property and equipment
          (121 )
Changes in operating assets and liabilities:
               
Accounts receivable
    (17,554 )     (2,778 )
Inventory
    134       202  
Prepaid expenses and other, net
    2,931       6,337  
Accounts payable
    (8,631 )     (1,548 )
Accrued expenses
    (106 )     (3,177 )
Deferred revenue
    8,711       3,155  
 
           
Net cash provided by operating activities
    22,957       29,656  
Cash flows from investing activities:
               
Proceeds from maturities and sales of available-for-sale securities
    45,846       464,352  
Purchases of available-for-sale securities
    (2,550 )     (285,351 )
Purchases of property and equipment
    (11,892 )     (6,568 )
Proceeds received from sale of property and equipment
    400       417  
Cash paid in business combinations, net of cash acquired
    (70,775 )     (70 )
 
           
Net cash (used in) provided by investing activities
    (38,971 )     172,780  
Cash flows from financing activities:
               
Proceeds from issuance of common stock
    13,170       10,885  
Net proceeds from issuance of preferred shares
          98,115  
Payments of notes payable and other
    (63 )     (95 )
Purchases of treasury stock
          (4,877 )
 
           
Net cash provided by financing activities
    13,107       104,028  
Effect of exchange rates on cash
    (358 )     (194 )
 
           
Net (decrease) increase in cash and cash equivalents
    (3,265 )     306,270  
Cash and cash equivalents at beginning of period
    46,019       39,648  
 
           
Cash and cash equivalents at end of period
  $ 42,754     $ 345,918